Histological response is not a prognostic factor after neoadjuvant chemotherapy in advanced-stage ovarian cancer with no residual disease.


OBJECTIVE The aim of this study was to evaluate the prognostic impact of the histological response at the time of interval debulking surgery (IDS) in patients treated with neoadjuvant chemotherapy (NACT) for unresectable advanced-stage ovarian cancer (ASOC). STUDY DESIGN A retrospective study to select cases fulfilling 4 inclusion criteria: (1) patients… (More)
DOI: 10.1016/j.ejogrb.2009.07.016